Levobren

Levosulpiride, the active ingredient in Levobren, is a D2 receptor antagonist (benzamide derivative) presented as oral tablets for oral use. It is employed to manage psychotic symptoms in schizophrenia and related disorders, as well as to improve gastrointestinal motility in functional dyspepsia and gastro‑oesophageal reflux disease.

GNH USA supplies Levobren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Levosulpiride is used in psychiatric and gastrointestinal pathways to treat several recognized conditions. - Schizophrenia: reduces positive psychotic symptoms and improves overall mental stability. - Depressive disorders: augments antidepressant therapy and alleviates depressive symptoms in certain patients. - Functional dyspepsia: enhances gastric emptying and relieves upper abdominal discomfort. - Gastroesophageal reflux disease: improves lower esophageal sphincter tone and reduces reflux episodes. - Anxiety disorders: mitigates anxiety symptoms associated with dopaminergic dysregulation.

Levosulpiride may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Increased prolactin: breast tenderness or galactorrhea.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Severe extrapyramidal reactions: acute dystonia or parkinsonism. - Cardiac arrhythmias: QT interval prolongation.

When prescribing levosulpiride, clinicians should consider several precautionary measures to ensure safe use. - Monitor for extrapyramidal symptoms: assess movement disorders regularly. - Check prolactin levels: watch for galactorrhea or menstrual disturbances. - Evaluate cardiac risk: obtain baseline ECG if patient has cardiac history. - Use cautiously in hepatic impairment: adjust dose or monitor liver function. - Avoid abrupt discontinuation: taper gradually to reduce withdrawal effects. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Levosulpiride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antipsychotics with strong D2 antagonism: may increase risk of extrapyramidal symptoms. - QT‑prolonging agents: can exacerbate cardiac arrhythmia risk. - CYP3A4 inhibitors (e.g., ketoconazole): raise levosulpiride plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may reduce pro‑kinetic benefit. - MAO inhibitors: potential for additive central nervous system effects. - CNS depressants (e.g., benzodiazepines): may enhance sedation.